Published: Jan 12, 2022
The Public Health Ministry is urging people in risk groups, such as the elderly and those who need to take immunosuppressive drugs, to get a fourth vaccine dose three months after receiving the third dose to stimulate immunity against Covid-19, Department of Disease Control director-general Dr Opas Karnkawinpong said on Wednesday.
Published: Dec 22, 2021
AstraZeneca and Oxford University have started developing a version of their coronavirus shot that targets omicron, as researchers study the efficacy of existing vaccines against the latest variant.
Published: Nov 19, 2021
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths with AZD7442 Separate treatment trial showed 88 per cent reduced risk of severe Covid-19 or death when treated within three days of symptom onset
Published: Nov 18, 2021
AstraZenecas Covid-19 antibody cocktail was more than 80% successful at both preventing symptomatic disease for six months and stopping the illness from worsening, demonstrating its ability to provide strong and long-lasting protection.